Nova Eye Medical Limited
ELXMF
$0.10
-$0.086-46.24%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 40.83% | 42.10% | 44.10% | 15.16% | -25.44% |
| Total Depreciation and Amortization | 20.49% | 3.73% | -10.03% | -15.08% | -19.54% |
| Total Amortization of Deferred Charges | -30.90% | 69.39% | -- | -- | -- |
| Total Other Non-Cash Items | -90.46% | -96.72% | -102.24% | 26.69% | 334.30% |
| Change in Net Operating Assets | -1,104.03% | -1,104.03% | -1,104.03% | -163.50% | -92.49% |
| Cash from Operations | -13.79% | -14.36% | -12.98% | 10.50% | 28.38% |
| Capital Expenditure | 70.40% | 49.95% | 22.18% | -1,505.88% | -257.34% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 103.45% | 89.05% | 85.74% | 95.17% | 96.52% |
| Cash from Investing | 77.97% | 67.91% | 61.68% | 70.23% | 73.56% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 23.32% | 22.04% | 20.67% | -5.37% | -39.24% |
| Issuance of Common Stock | -0.54% | -0.54% | -0.54% | 99.46% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -0.99% | -1.17% | -1.22% | 110.23% | 1,419.99% |
| Foreign Exchange rate Adjustments | 69.23% | -21.94% | -98.32% | 76.68% | 247.92% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -362.77% | -413.09% | -121.45% | 90.31% | 101.23% |